New Drug Applications
November 18th, 2009
To ease the discomfort of sickness or vomiting after an operation, new research has discovered that taking dextrose (a form of glucose) will prevent post-op nausea.
“As one of the most common post-operative complications, [vomiting and nausea] remains one of the main causes of decreased patient satisfaction following surgery,” says an author of the new study, [...]
November 17th, 2009
Treatment with Xenical weight loss drug combined with a low-calorie diet, exercise and behavioural therapy has been found to help obese teenagers lose weight and improve weight management, suggests a new study.
Behavioural modification, by itself, has not been successful for maintaining weight loss in adolescents struggling with obesity. Investigators are saying that there is a [...]
November 13th, 2009
New research tested a new class of experimental drugs to target the disease process that comes with lupus. Benlysta was one of the most promising drugs to beat out typical treatment in the large clinical trial.
If the results of the research are accurate, Benlysta would become the first new treatment for lupus in over fifty [...]
November 10th, 2009
A new way to help people lose weight has been found with the diabetes medication liraglutide. This prescription drug has been found to help obese people without diabetes lose weight.
Authors of the study have also revealed surprising information that shows that high doses of liraglutide can be more successful at helping shed pounds than the [...]
October 2nd, 2009
The H1N1 Swine flu has claimed the lives of 28 pregnant women in the United States creating worry from obstetricians and CDC investigators. The 28 victims of severe H1N1 swine flu were among 100 pregnant women throughout the country requiring hospitalization.
In the past, the flu has only drawn mild concern for pregnant women and to her fetus. It is not known whether H1N1 Swine flu is any worse.
September 10th, 2009
GlaxoSmithKline recently advised the public that the US FDA’s Vaccines and Related Biological Products Advisory Committee voted that Ceravix, the company’s cervical cancer vaccine, presented data that substantiates the efficacy and safety of the treatment.
August 17th, 2009
The US FDA has approved Saphris sublingual tablets for the acute therapy of schizophrenic adults, as well as the acute therapy of manic or mixed bipolar I disorder, with or without adult psychotic attributes. Saphris is endorsed for first-line therapy, and is the first prescription drug to receive primary consent for both of these symptoms concurrently.
August 6th, 2009
Human Genome Sciences and GlaxoSmithKline, recently announced impressive results from their yearlong clinical trial for lupus treatment Benlysta
